STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,169,265)	$ (2,961,194)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	76,425	37,683
Change in market value of settlement related financial instruments		295,000
Stock-based compensation expense	26,109	41,416
Loss on disposal of assets		3,471
Changes in assets and liabilities:
Accounts receivable	(91,408)	7,961
Contracts receivable	(6,200)
Prepaid expenses	(85,706)	116,998
Other assets	(168)	(10,370)
Deferred revenue	92,351	5,387
Accounts payable	217,806	(4,447)
Accrued and other expenses	394,385	(1,152,612)
Net cash used in operating activities	(2,545,671)	(3,620,707)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of furniture and equipment	(25,530)	(10,052)
Purchase of software license	(75,000)
Capitalized patent development costs	(17,248)
Capitalized software	(749,160)
Net cash used in investing activities	(866,938)	(10,052)
CASH FLOWS FROM FINANCING ACTIVITIES:
Restricted cash used to pay IDB interest expense and fees	152,904	128,997
Repayments on notes payable	(12,172)	(2,683)
Deposit of funds to IDB restricted account	(281,341)
Debt borrowings	3,639,253	2,875,000
Net cash provided by financing activities	3,498,644	3,001,314
NET (DECREASE) IN CASH AND CASH EQUIVALENTS	86,035	(629,445)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	165,139	860,211
CASH AND CASH EQUIVALENTS, END OF PERIOD	251,174	230,766
Supplemental disclosures of cash flow information:
Cash paid during the period for: Interest	$ 1,161,288	$ 926,931